Abstract
Get full access to this article
View all access options for this article.
References
1.
Özsoylu S.
,
Ruacan S.
High-dose intravenous corticosteroid treatment in childhood idiopathic myelofibrosis . Acta Haematol.
1986 ;75 :49 -51 .
2.
Özsoylu S.
High-dose intravenous methylprednisolone (HIVMP) in haematologic disorders . Hematol Rev.
1990 ;4 :197 -207 . In press.
3.
Ozsoylu S.
,
Ruacan S.
,
Karaaslan Y.
,
Dündar S.
Megadose intravenous methylprednisolone in adult idiopathic myelofibrosis
Hematol Rev . In press.
4.
Ozsoylu S.
,
Irkeneq G.
,
Karabent A.
High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura . Eur J Haematol . 1989 ;42 :431 -435 .
5.
Ozsoylu S.
,
Ertürk G.
Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura . Blood . 1991 ;77 :1856 -1857 .
6.
Hicsönmez G.
,
Ozsoylu S.
,
Tuncer AM
Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential . Leukemia Research (In press).
7.
Ozsoylu S.
,
Ruacan S.
High-dose intravenous corticosteroid treatment in childhood idiopathic myelofibrosis . Acta Haematol.
1986 ;75 :49 -51 .
8.
Rosenberg HS
,
Taylor FM
The myeloproliferative syndrome in children . J Pediatr.
1985 ;52 :407 -415 .
9.Myelofibrosis . Lancet.
1980 ;1 :127 -129 . Editorial.
10.
Boxer LA
,
Camitta BM
,
Berenberg W.
, et al. Myelofibrosis — myeloid metaplasia in childhood . Pediatrics . 1985 ;55 :861 -865 .